Annovis Bio, Inc. SEC filings ANVS
Annovis Bio, Inc. has 314 filings in SEC EDGAR's recent list, going back to Jan 15, 2010. Its latest annual report, Form 10-K, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 7, 2026 | — |
| DEF 14A | Proxy statement | Sep 11, 2026 | Oct 14, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 25, 2026 | Aug 24, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 17, 2026 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 17, 2025 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 12, 2024 |
| DEFA14A | Additional proxy material | Jun 2, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 15, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | Jun 15, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2022 | — |
| DEF 14A | Proxy statement | Apr 18, 2022 | Jun 2, 2022 |
| DEFA14A | Additional proxy material | Apr 19, 2021 | — |
| DEF 14A | Proxy statement | Apr 19, 2021 | Jun 1, 2021 |
| DEFA14A | Additional proxy material | Jun 1, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 3, 2020 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1477845
- Former names
- QR Pharma, Inc. (until Mar 15, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.